Affiance Financial’s Xylem XYL Stock Holding History

Affiance Financial’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$55.3K	–	425
2022 Q4	$55.3K	Buy	+500	New	+$52.4K	0.02%	164

Other funds holding XYL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Affiance Financial's XYL Position: Q1 2023 in Review

Affiance Financial sold out of Xylem (XYL) in Q1 2023, closing a stake of 500 shares — an estimated $55.3K sold.

Affiance Financial first reported a position in XYL in Q4 2022 and held it in 1 quarter. The position peaked at $55.3K in Q4 2022. 837 funds tracked by Wall St. Rank hold XYL as of Q1 2023.

Affiance Financial reported no remaining Xylem position as of Q1 2023 after selling out during the quarter.
Affiance Financial sold 500 Xylem shares in Q1 2023, an estimated $55.3K.
Affiance Financial first reported a position in Xylem in Q4 2022 and held it in 1 quarter.
Affiance Financial's Xylem position peaked at $55.3K in Q4 2022.
837 funds tracked by Wall St. Rank held Xylem as of Q1 2023.

Based on Affiance Financial's 13F filing for Q1 2023, filed 18 Apr 2023.